Stock Alert: Aclaris Therapeutics Up 40%

(RTTNews) - Shares of Aclaris Therapeutics, Inc. (ACRS) are currently gaining nearly 40% on Monday morning despite no stock-specific news. Pharma companies are performing better on Monday as investors are more interested in the industry on the back of positive reports of COVID-19 vaccine.

ACRS is currently trading at $3.08, up $0.87 or 39.37%, on the Nasdaq.

Aclaris Therapeutics is a biopharmaceutical company focused on developing drug candidates for immuno-inflammatory diseases in the US. It operates in two segments, Therapeutics and Contract Research.

Meanwhile, a coronavirus vaccine the University of Oxford is developing with AstraZeneca demonstrated promising results in early human testing.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More